Fibrodyplasia Ossificans Progressiva Fop clinical trials

Explore recruiting fibrodyplasia ossificans progressiva fop clinical trials.

Also recruiting in Europe

Fibrodyplasia Ossificans Progressiva Fop trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety, tolerability and immunogenicity of fractional, intradermal mRNA SARS-CoV-2 vaccination in patients with Fibrodysplasia Ossificans Progressiva (IVY trial)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Saracatinib trial TO Prevent FOP (STOPFOP)

Germany, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Fibrodyplasia Ossificans Progressiva Fop trials by city

Fibrodyplasia Ossificans Progressiva Fop in Toronto Fibrodyplasia Ossificans Progressiva Fop in Vancouver Fibrodyplasia Ossificans Progressiva Fop in Montreal Fibrodyplasia Ossificans Progressiva Fop in Calgary Fibrodyplasia Ossificans Progressiva Fop in Edmonton Fibrodyplasia Ossificans Progressiva Fop in Ottawa Fibrodyplasia Ossificans Progressiva Fop in Winnipeg Fibrodyplasia Ossificans Progressiva Fop in Quebec City Fibrodyplasia Ossificans Progressiva Fop in Hamilton Fibrodyplasia Ossificans Progressiva Fop in Kitchener Fibrodyplasia Ossificans Progressiva Fop in London Fibrodyplasia Ossificans Progressiva Fop in Halifax Fibrodyplasia Ossificans Progressiva Fop in New York Fibrodyplasia Ossificans Progressiva Fop in Los Angeles Fibrodyplasia Ossificans Progressiva Fop in Chicago Fibrodyplasia Ossificans Progressiva Fop in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease